Clinical Trials

170 enrolled

Phase 2/3 Active not recruiting

Neoplasms

NCT02491632 2026-03-18

Physical Activity and Dexamethasone in Reducing Cancer-Related Fatigue in Patients With Advanced Cancer

90 enrolled 13 charts

Fatigue, Neoplasm Metastasis, Neoplasms, Recurrence

NCT04904588 2026-03-18

ACCESS

LymphoidMyeloidOther hematologic neoplasmOther neoplasm

300 enrolled

Bone Marrow Diseases, Hematologic Diseases, Immune System Diseases, Immunoproliferative Disorders, Leukemia, Leukemia, Lymphoid, Leukemia, Myeloid, Lymphatic Diseases, Lymphoma, Lymphoproliferative Disorders, Myelodysplastic Syndromes, Neoplasms, Neoplasms by Histologic Type, Precancerous Conditions, Preleukemia, Leukemia, B-Cell, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Biphenotypic, Acute, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT06606847 2026-03-18

LADOGA

30 enrolled

Thoracic

Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, Lung Diseases, Lung Neoplasms, Neoplasms, Neoplasms by Site, Respiratory Tract Diseases, Respiratory Tract Neoplasms, Thoracic Neoplasms

NCT04958239 2026-03-17

A Study to Test BI 765179 Alone and in Combination With Ezabenlimab in Patients With Advanced Cancer (Solid Tumors) and BI 765179 in Combination With Pembrolizumab in Patients With Advanced Head and Neck Cancer

151 enrolled

Neoplasms

NCT07038369 2026-03-17

A Phase 1 Study of ATV-1601 in Patients With Advanced Cancer That Have AKT1 E17K Mutations

BreastGenitourinaryGynecologic

134 enrolled

Breast Diseases, Breast Neoplasms, Uterine Cervical Neoplasms, Genital Neoplasms, Female, Neoplasms, Neoplasms by Site, Ovarian Neoplasms, Prostatic Neoplasms, Urogenital Neoplasms, Uterine Neoplasms, Endometrial Neoplasms, Triple Negative Breast Neoplasms

NCT07474168 2026-03-16

T Cell Receptor Gene-Engineered and Dominant Negative TGF-β Receptor T Cell Therapy Targeting KRAS Mutations in the Treatment of Subjects With Advanced Solid Tumor

9 enrolled

Neoplasms

NCT02808780 2026-03-13

OPAL

Phase 1/2 Active not recruiting

537 enrolled

Lymphoid

Colitis, Ulcerative, Lymphoma, Neoplasms

NCT02908906 2026-03-12

A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of JNJ-63723283, an Anti-PD-1 Monoclonal Antibody, in Participants With Advanced Cancers

413 enrolled

Neoplasms

NCT04328350 2026-03-12

Social Experiences of Adolescents and Young Adults With Cancer

121 enrolled

Neoplasms, Social Behavior, Social Skills

NCT04618913 2026-03-12

VICTORIE

1 enrolled

Classical hematology

Embolism, Neoplasms, Venous Thromboembolism

NCT04803604 2026-03-12

CASCADE

256 enrolled

Neoplasms

NCT04905069 2026-03-12

SABRE

500 enrolled

Neoplasms, Prostatic Neoplasms

NCT06824441 2026-03-12

Feasibility Usability & Acceptability Study: Symptom Reporting by Children Adolescents & Young Adults w/Cancer

83 enrolled

Adolescent Behavior, Neoplasms

NCT07468422 2026-03-12

OPTin

200 enrolled

Neoplasms

NCT00001163 2026-03-11

Clinical, Laboratory, and Epidemiologic Characterization of Individuals and Families at High Risk of Cancer

5,201 enrolled

Neoplasms

NCT00092222 2026-03-11

Virotherapy and Natural History Study of KHSV-Associated Multricentric Castleman s Disease With Correlates of Disease Activity

75 enrolled

Lymphoid

Multi-centric Castleman's Disease, Macular dystrophy, corneal type 1, Lymphadenopathy, Lymphoproliferative Disorders, Neoplasms, HIV Infections

NCT05763797 2026-03-11

Developing a Culturally Relevant Supportive Care Program for Black Patients Dealing With Advanced Cancer

170 enrolled

Neoplasms

NCT05993299 2026-03-11

Study to Evaluate Safety and Antitumor Activity of Lete-Cel (GSK3377794) in HLA-A2+ Participants With NY-ESO-1 Positive Previously Untreated Advanced (Metastatic or Unresectable) Synovial Sarcoma and Myxoid/Round Cell Liposarcoma

7 enrolled 15 charts

Neoplasms

NCT06864260 2026-03-11

PREEMpT

300 enrolled

Neoplasms

NCT05707910 2026-03-09

Clinical Study of Therapeutic Immunological Agent for EBV-positive Advanced Malignant Tumors

6 enrolled

Neoplasms

NCT06549153 2026-03-09

ACT-Together (Acting on Cancer Testing-Together)

30 enrolled

Neoplasms

NCT07217145 2026-03-09

PREVENT HPV -Related Cancers Trial

1,455 enrolled

Behavior, Communication, Neoplasms, Patient Acceptance of Health Care, Papillomavirus Infections

NCT00339495 2026-03-06

Prostate Lung Colorectal and Ovarian (PLCO) Cancer Screening Trial

154,900 enrolled

Death, Neoplasms

NCT00352924 2026-03-06

Agriculture Health Study

GenitourinaryLymphoidPlasma cell

89,655 enrolled

Lymphoma, Multiple Myeloma, Neoplasms, Prostatic Neoplasms

NCT00835133 2026-03-06

Collecting Blood and Tissue Samples From Family Members of Patients With Pancreatic Diseases, Pancreatic Cancer, and Melanoma

DermatologicGastrointestinal

1,122 enrolled

Pancreatic carcinoma, familial, Melanoma, Neoplasms

NCT01428895 2026-03-06

Femoral Bone Metastases

180 enrolled

Neoplasms

NCT03264664 2026-03-06

Study of E7386 in Participants With Selected Advanced Neoplasms

Phase 3 Active not recruiting

60 enrolled

Gastrointestinal

Carcinoma, Hepatocellular, Neoplasms

NCT03844048 2026-03-06

An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial

165 enrolled

LymphoidOther hematologic neoplasmPlasma cell

Lymphoma, Non-Hodgkin, Multiple Myeloma, Neoplasms, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT03260491 2026-03-05

U3-1402 in Metastatic or Unresectable Non-Small Cell Lung Cancer

312 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis, Neoplasms

NCT04135794 2026-03-05

MRL1

377 enrolled

Neoplasms

NCT04307914 2026-03-05

FURTHER

216 enrolled

Sarcoma

Bone Neoplasms, Neoplasm Metastasis, Neoplasms, Pain

NCT05331638 2026-03-05

PCGA

80 enrolled

Neoplasms, Prostatic Neoplasms, Health Behavior

NCT05611632 2026-03-05

NHS-Galleri

142,318 enrolled

Neoplasms

NCT05941897 2026-03-05

LOTOS

39 enrolled

Thoracic

Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, Lung Diseases, Lung Neoplasms, Neoplasms, Neoplasms by Site, Respiratory Tract Diseases, Respiratory Tract Neoplasms, Thoracic Neoplasms

NCT04267861 2026-03-04

M7824 Related Adverse Effects in Adults With Cancer

Phase 1/2 Active not recruiting

232 enrolled

Dermatologic

Neoplasms, Skin Neoplasms

NCT05520567 2026-03-04

A Study of Gilteritinib, Venetoclax and Azacitidine as a Combined Treatment for People Newly Diagnosed With Acute Myeloid Leukemia

70 enrolled

Other hematologic neoplasm

Neoplasms, Leukemia, Myeloid, Acute

NCT05946993 2026-03-04

LIAM Mc

72 enrolled

Kidney Neoplasms, Neoplasms, Penile Neoplasms, Prostatic Neoplasms, Testicular Neoplasms, Urologic Neoplasms

NCT00832325 2026-03-03

Adolescent and Young Adult Cancer Survivors: Identity Development

300 enrolled

Neoplasms

NCT04913259 2026-03-03

TS-PAC

33 enrolled 8 charts

Phase 3 Active not recruiting

Neoplasms

NCT05154162 2026-03-03

PRIMARY2

660 enrolled

Neoplasms, Prostatic Neoplasms

NCT02574728 2026-03-02

AflacST1502

46 enrolled

CNSMyeloidSarcoma

Brain Neoplasms, Carcinoma, Ependymoma, Histiocytosis, Langerhans-Cell, Medulloblastoma, Neoplasms, Neoplasms, Germ Cell and Embryonal, Neuroblastoma, Pinealoma, Rhabdomyosarcoma, Sarcoma, Sarcoma, Ewing, Osteosarcoma, Rhabdoid Tumor

NCT05063565 2026-03-02

ROWAN